Watch: Fired CDC Chief Says RFK Jr. Insisted She Roll Back Vaccine Policies Without Evidence
Susan Monarez and former Centers for Disease Control and Prevention chief medical officer Debra Houry described turmoil in an agency dominated by anti-vaccine political officials nominated by Health and Human Services Secretary Robert F. Kennedy Jr.
Under Trump, FDA Seeks To Abandon Expert Reviews of New Drugs
Advisory committee meetings help FDA scientists make decisions and increase public understanding of drug regulation, and abandoning them doesn’t make sense, former officials said.
Changes at NIH Give Political Appointees Greater Power To Fund or Block Research
The National Institutes of Health’s long-held standard of peer review for grantmaking has been subverted by President Donald Trump and NIH Director Jay Bhattacharya, who gave unprecedented power to politicos, NIH workers say.
FTC Has Long Said Products Must Back Up Health Claims. A MAHA Lawsuit Would Upend That.
Xlear, a maker of xylitol gum, has sued the Federal Trade Commission, saying the onus should be on government to prove that ingredients don’t live up to advertised claims. RFK Jr.’s “medical freedom” allies have rallied to the cause.
World’s Premier Cancer Institute Faces Crippling Cuts and Chaos
After spearheading a 34% cut in cancer mortality, the National Cancer Institute at the NIH is bleeding resources and staff and could see its budget cut by nearly 40%.
Kennedy’s Vaccine Advisers Sow Doubts as Scientists Protest US Pivot on Shots
A new vaccine advisory panel appointed by the Health and Human Services secretary, a longtime anti-vaccine activist, reflected his unsupported claims about the safety of childhood inoculations.
What RFK Jr. Isn’t Talking About: How To Make Vaccines Safer
Vaccines are under fire from the top of the Trump administration. Federal programs to monitor them and make them safer have always been underfunded.
Two Patients Faced Chemo. The One Who Survived Demanded a Test To See if It Was Safe.
Worried that President Donald Trump’s FDA might not act, a panel of cancer experts recommended that doctors consider testing before dosing patients with a commonly used but sometimes deadly cancer drug. It came too late for many patients.
Double Blow: Drug Tariffs and Wage Hikes Threaten California’s Pharmacies
While Big Pharma seems ready to weather the tariff storm, independent pharmacists and makers of generic drugs — which account for 90% of U.S. prescriptions — see trouble ahead for patients.
Trump Team’s $500 Million Bet on Old Vaccine Technology Puzzles Scientists
Secretary Robert F. Kennedy Jr.’s HHS said an enormous, noncompetitive flu vaccine development grant to two favored NIH leaders would ensure “transparency, effectiveness, and comprehensive preparedness.” But their vaccine is in early stages, relies on old technology, and is just one of scores of similar efforts.